Skip to main content
Journal cover image

Evaluation of opioid requirements in mechanically ventilated patients taking buprenorphine/naloxone prior to admission.

Publication ,  Journal Article
O'Connell, M; Kamp, A; Mertz, S; Kuhrt, M; Yang, LZ; Erkanli, A; Cox, CE; Kram, B
Published in: J Crit Care
February 2026

BACKGROUND: With limited data quantifying opioid requirements based on substance use history, including buprenorphine/naloxone use, optimal pain management for mechanically ventilated patients remains unknown. OBJECTIVE: To compare opioid requirements in mechanically ventilated adults admitted to the intensive care unit (ICU) taking buprenorphine/naloxone prior to admission compared to those who do not. METHODS: This multicenter, retrospective study included adults admitted to a medical ICU and mechanically ventilated for at least 12 h. The primary endpoint was mean hourly opioid rate (fentanyl equivalents [FE], μg FE/h) from intubation until extubation or up to 72 h. Secondary endpoints included sedative requirements and time with pain and depth of sedation scores within goal. To adjust for confounders, a negative binomial model was performed. RESULTS: Of 176 patients, 47 took buprenorphine/naloxone, 69 were opioid-naïve, and 60 were opioid-tolerant. There was no difference in mean hourly opioid rate between buprenorphine/naloxone (40.8 ± 37.1 μg FE/h) and opioid-naïve (31.7 ± 32.5 μg FE/h; p = 0.17) and opioid-tolerant patients (51 ± 46 μg FE/h; p = 0.22). Multivariable regression demonstrated similar hourly rates in buprenorphine/naloxone and opioid-naïve patients, but opioid-tolerant patients had 50 % higher rates (estimated rate ratio 1.5, 95 % CI [1.01, 2.23]). Time spent with pain scores at goal was similar. Time spent with sedation scores at goal was similar between buprenorphine/naloxone and opioid-naïve patients, but was lower than opioid-tolerant patients. CONCLUSION: Patients taking buprenorphine/naloxone prior to admission who are mechanically ventilated for at least 12 h may have opioid requirements similar to opioid-naïve patients and lower than opioid-tolerant patients.

Duke Scholars

Published In

J Crit Care

DOI

EISSN

1557-8615

Publication Date

February 2026

Volume

91

Start / End Page

155261

Location

United States

Related Subject Headings

  • Retrospective Studies
  • Respiration, Artificial
  • Pain Management
  • Narcotic Antagonists
  • Naloxone
  • Middle Aged
  • Male
  • Intensive Care Units
  • Humans
  • Female
 

Citation

APA
Chicago
ICMJE
MLA
NLM
O’Connell, M., Kamp, A., Mertz, S., Kuhrt, M., Yang, L. Z., Erkanli, A., … Kram, B. (2026). Evaluation of opioid requirements in mechanically ventilated patients taking buprenorphine/naloxone prior to admission. J Crit Care, 91, 155261. https://doi.org/10.1016/j.jcrc.2025.155261
O’Connell, Molly, Ashley Kamp, Sean Mertz, Michelle Kuhrt, Lexie Zidanyue Yang, Alaattin Erkanli, Christopher E. Cox, and Bridgette Kram. “Evaluation of opioid requirements in mechanically ventilated patients taking buprenorphine/naloxone prior to admission.J Crit Care 91 (February 2026): 155261. https://doi.org/10.1016/j.jcrc.2025.155261.
O’Connell M, Kamp A, Mertz S, Kuhrt M, Yang LZ, Erkanli A, et al. Evaluation of opioid requirements in mechanically ventilated patients taking buprenorphine/naloxone prior to admission. J Crit Care. 2026 Feb;91:155261.
O’Connell, Molly, et al. “Evaluation of opioid requirements in mechanically ventilated patients taking buprenorphine/naloxone prior to admission.J Crit Care, vol. 91, Feb. 2026, p. 155261. Pubmed, doi:10.1016/j.jcrc.2025.155261.
O’Connell M, Kamp A, Mertz S, Kuhrt M, Yang LZ, Erkanli A, Cox CE, Kram B. Evaluation of opioid requirements in mechanically ventilated patients taking buprenorphine/naloxone prior to admission. J Crit Care. 2026 Feb;91:155261.
Journal cover image

Published In

J Crit Care

DOI

EISSN

1557-8615

Publication Date

February 2026

Volume

91

Start / End Page

155261

Location

United States

Related Subject Headings

  • Retrospective Studies
  • Respiration, Artificial
  • Pain Management
  • Narcotic Antagonists
  • Naloxone
  • Middle Aged
  • Male
  • Intensive Care Units
  • Humans
  • Female